ClinicalTrials.gov
ClinicalTrials.gov Menu

Cloretazine (VNP40101M) With Hematopoietic Cell Transplantation for Hematologic Malignancies

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00521859
Recruitment Status : Completed
First Posted : August 28, 2007
Last Update Posted : July 31, 2012
Sponsor:
Collaborator:
Vion Pharmaceuticals
Information provided by (Responsible Party):
M.D. Anderson Cancer Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : December 2010
  Actual Study Completion Date : December 2010